GAT Data Gallery
The Genomic Antibody Technology™ has been used in over 3000 antibody development projects. The resulting antibodies have been evaluated in a wide range of immunoassay formats. High success rates* have been observed not only for generating a successful antibody but also across a wide range of different immunoassay formats.
View how GAT performed in the following applications:
*Note: success in an immunoassay depends on three general risk factors:
1) inherent difficulties of the target in generating antibodies (eg. highly conserved proteins),
2) risks around the quality and nature of the antigen (eg synthetic peptides versus whole protein, purity), and
3) risks from the immunoassay (eg quality of the samples and the technical execution of the assay).
Not all the risks could be controlled in experiments performed by outside collaborators to allow for precise success rates.